M.D. Anderson Cancer Center: Thrombocytopenia trials
The registry lists 10 Thrombocytopenia studies with M.D. Anderson Cancer Center as lead sponsor. 0 are open to participants now and 8 have results posted.
Phase 1 1Phase 2 8Phase 3 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic LeukemiaCompletedNCT02530515Phase 2Results posted
- Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase TherapyCompletedNCT01428635Phase 2/3Results posted
- Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL)CompletedNCT01168921Phase 2Results posted
- Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT01002755Phase 2Results posted
- Eltrombopag for Post Transplant ThrombocytopeniaCompletedNCT01000051Phase 2Results posted
- Aspirin in Patients With Myocardial Infarction and ThrombocytopeniaTerminatedNCT00501345Phase 3Results posted
- Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) PatientsCompletedNCT00493181Phase 2Results posted
- AMG 531 in Patients With Advanced Malignancy Receiving Treatment With CarboplatinCompletedNCT00147225Phase 1/2Results posted
- 177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and CytopeniaWithdrawnNCT07025512Phase 2
- Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous PlateletsTerminatedNCT00074763Phase 3